✦ LIBER ✦

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non-Small-Cell Lung Cancer

✍ Scribed by Sequist, L. V.; von Pawel, J.; Garmey, E. G.; Akerley, W. L.; Brugger, W.; Ferrari, D.; Chen, Y.; Costa, D. B.; Gerber, D. E.; Orlov, S.; Ramlau, R.; Arthur, S.; Gorbachevsky, I.; Schwartz, B.; Schiller, J. H.

Book ID: 125511597
Publisher: American Society of Clinical Oncology
Year: 2011
Tongue: English
Weight: 205 KB
Volume: 29
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2010.34.0570

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale and Design of MARQUEE: A Phase

Rationale and Design of MARQUEE: A Phase III, Randomized, Double-Blind Study of Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Patients With Locally Advanced or Metastatic, Nonsquamous, Non–Small-Cell Lung Cancer

✍ Giorgio V. Scagliotti; Silvia Novello; Joan H. Schiller; Vera Hirsh; Lecia V. Se 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 332 KB

9174 Phase II study of everolimus plus e

9174 Phase II study of everolimus plus erlotinib in previously treated patients with advanced non-small cell lung cancer (NSCLC)

✍ Soria, J.C.; Bennouna, J.; Leighl, N.; Khuri, F.; Traynor, A.M.; Johnson, B.; Ka 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Randomized, Placebo-Controlled Phase II

Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non Small-Cell Lung Cancer

✍ Heymach, J. V.; Johnson, B. E.; Prager, D.; Csada, E.; Roubec, J.; Pesek, M.; Sp 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 209 KB

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer

✍ Spigel, D. R.; Burris, H. A.; Greco, F. A.; Shipley, D. L.; Friedman, E. K.; Wat 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 161 KB

A randomized phase II study comparing er

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study

✍ Aerts, J. G.; Codrington, H.; Lankheet, N. A. G.; Burgers, S.; Biesma, B.; Dinge 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 315 KB

A Randomized Phase II Study of Gefitinib

A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

✍ Han, J.-Y.; Lee, S.-H.; Yoo, N. J.; Hyung, L. S.; Moon, Y. J.; Yun, T.; Kim, H. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 317 KB